# EDGAR Filing Document

**Accession Number:** 0000355811
**File Stem:** 0001562180-23-000792
**Filing Date:** 2023-2
**Character Count:** 9265
**Document Hash:** 549bc77030a9fbae626c13e89ae3e720
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001562180-23-000792.hdr.sgml**: 20230202

**ACCESSION NUMBER**: 0001562180-23-000792

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230201

**FILED AS OF DATE**: 20230202

**DATE AS OF CHANGE**: 20230202

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Nash Kevin C
- **CENTRAL INDEX KEY:** 0001577359

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-10235
- **FILM NUMBER:** 23579191

**MAIL ADDRESS:**
- **STREET 1:** 2608 104TH AVENUE
- **CITY:** ZEELAND
- **STATE:** MI
- **ZIP:** 49464
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GENTEX CORP
- **CENTRAL INDEX KEY:** 0000355811
- **STANDARD INDUSTRIAL CLASSIFICATION:** MOTOR VEHICLE PARTS & ACCESSORIES [3714]
- **IRS NUMBER:** 382030505
- **STATE OF INCORPORATION:** MI
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 600 N CENTENNIAL ST
- **CITY:** ZEELAND
- **STATE:** MI
- **ZIP:** 49464
- **BUSINESS PHONE:** 6167721800

**MAIL ADDRESS:**
- **STREET 1:** 600 N CENTENNIAL STREET
- **CITY:** ZEELAND
- **STATE:** MI
- **ZIP:** 49464

## Ex-24

```

POWER OF ATTORNEY

      Know all by these presents, that the undersigned hereby
constitutes and appoints each of Steve Downing, any successor as
Chief Executive Officer of Gentex Corporation (the "Corporation"),
and Scott Ryan, any successor as General counsel of Gentex
Corporation, and any of their respective designees, signing singly,
the undersigned's true and lawful attorney-in-fact to:

            (1)	execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director of the
Corporation, Forms 3, 4, and 5 in accordance with Section 16(a) of
the Securities Exchange Act of 1934 and the rules thereunder;

            (2)	do and perform any and all acts for and on behalf of
the undersigned that may be necessary or desirable to complete and
execute any such Form 3, 4, or 5, complete and execute any amendment
or amendments thereto, and timely file such form with the United
States Securities and Exchange Commission and any stock exchange or
similar authority; and

            (3)	take any other action of any type whatsoever in
connection with the foregoing that, in the opinion of such attorney-
in-fact, may be of benefit to, in the best interest of, or legally
required by, the undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may
approve in such attorney-in-fact's discretion.

      The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing
whatsoever requisite, necessary, or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all
intents and purposes as the undersigned might or could do if
personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do
or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted.

      The undersigned acknowledges that the foregoing attorneys-in-
fact, in serving in such capacity at the request of the undersigned,
are not assuming, nor is the Corporation assuming, any of the
undersigned's responsibilities to comply with Section 16 or any other
provision of the Securities Exchange Act of 1934.

      This Power of Attorney revokes any and all previous power of
attorneys related to this subject matter, and shall remain in full
force and effect until the undersigned is no longer required to file
Forms 3, 4, and 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Corporation, unless earlier
revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 20th day of August, 2020.

Signature:/s/ Kevin Nash

Print Name: Kevin Nash

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Nash Kevin C<br><sub>(Last) (First) (Middle)</sub><br>600 NORTH CENTENNIAL STREET<br><sub>(Street)</sub><br>ZEELAND, MI 49464<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-01 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Financial Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>GENTEX CORP [ GNTX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-02-01 |  | M |  | 6776.00 | A | $14.70 | 28508.00 | D |  |
| Common Stock | 2023-02-01 |  | S |  | 6776.00<sup>(1)</sup> | D | 29.4233<sup>(2)</sup> | 22597.00<sup>(3)</sup> | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (Right to buy) | $14.70 | 2023-02-01 |  | M |  |  | 6776.00 | 2017-02-22<sup>(4)</sup> | 2023-02-22 | Common Stock | 6776.00 | $0.00 | 0.00 | D |  |

---

### Footnotes:

(1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

(2) This transaction was executed in multiple trades at prices ranging from $29.32 to $29.56. The price reported above reflects the weighted average price.

(3) Column 5 reflects the acquisition of 865 shares under the Gentex Corp. Employee Stock Purchase Plan.

(4) These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date.

**Signature:** /s/ Scott Ryan for Kevin C. Nash by Power of Attorney  
**Date:** 2023-02-02

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**